Issuer · CIK 0001395937

SNDX — Syndax Pharmaceuticals Inc

Recent filings

Jun 12, 2026·Form 4·Sell$617K
SNDX/Syndax Pharmaceuticals Inc
Botwood Nicholas A.J. · Head of R&D, CMO
Mechanical filing
AI thesis skipped

← Back to all filings

SNDX (Syndax Pharmaceuticals Inc) — recent insider filings — Form 4 AI